FLONASE® Safety
A well-established safety profile trusted by doctors and pharmacists for over 20 years1,2
FLONASE® Allergy Relief is well tolerated and has a well-established safety profile.1-43*
The safety profile of FLONASE® Allergy Relief is supported by a large number of clinical studies and close to 30 years of post marketing surveillance. The safety profile of FLONASE® Allergy Relief in an OTC environment has been demonstrated to be very similar to that of an Rx environment, based on almost 20 years of global post-marketing spontaneous data collection.3,4
Evidence confirms that FLONASE® Allergy Relief is minimally absorbed, has low toxicity, minimal medically significant systemic effects at recommended doses, and is well-tolerated with less than 1% of FPNS absorbed into the bloodstream.3-65
FEW CONCERNS WITH COMORBID CONDITIONS:
FLONASE® Allergy Relief is not associated with higher blood pressure as it is minimally absorbed systemically, and is not contraindicated in patients with hypertension, heart disease, diabetes, or kidney disease.4,6-11
LOW INCIDENCE OF SYSTEMIC ADVERSE EFFECTS:
FLONASE® Allergy Relief is not associated with anticholinergic side effects commonly associated with some other allergy medications, such as drowsiness, dry mouth, nervousness, dizziness, or sleeplessness.4,6-16
Read more about allergic rhinitis
Impact of Allergic Rhinitis on Patient Quality of Life
Find out about the impact allergic rhinitis has on patients’ daily lives
